These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 25012839

  • 21. Endoresection with adjuvant ruthenium brachytherapy for selected uveal melanoma patients - the Tuebingen experience.
    Süsskind D, Dürr C, Paulsen F, Kaulich T, Bartz-Schmidt KU.
    Acta Ophthalmol; 2017 Dec; 95(8):e727-e733. PubMed ID: 27914117
    [Abstract] [Full Text] [Related]

  • 22. [Criteria for assessing the efficacy of brachytherapy of uveal melanomas, complications of therapy and there prevention].
    Brovkina AF, Zarubeí GD, Val'skií VV.
    Vestn Oftalmol; 1997 Dec; 113(3):14-6. PubMed ID: 9265351
    [Abstract] [Full Text] [Related]

  • 23. Rates of local control, metastasis, and overall survival in patients with posterior uveal melanomas treated with ruthenium-106 plaques.
    Kleineidam M, Guthoff R, Bentzen SM.
    Radiother Oncol; 1993 Aug; 28(2):148-56. PubMed ID: 8248556
    [Abstract] [Full Text] [Related]

  • 24. [Long-term results of cobalt 60 curietherapy for uveal melanoma].
    Bacin F, Kwiatkowski F, Dalens H, Rozan R, Gagyi S, Donnarieix D, Bard JJ, Robert JL.
    J Fr Ophtalmol; 1998 May; 21(5):333-44. PubMed ID: 9759427
    [Abstract] [Full Text] [Related]

  • 25. Ruthenium-106 plaque brachytherapy for thick posterior uveal melanomas.
    Kaiserman N, Kaiserman I, Hendler K, Frenkel S, Pe'er J.
    Br J Ophthalmol; 2009 Sep; 93(9):1167-71. PubMed ID: 19570767
    [Abstract] [Full Text] [Related]

  • 26. A 17-year retrospective study of institutional results for eye plaque brachytherapy of uveal melanoma using (125)I, (103)Pd, and (131)Cs and historical perspective.
    Leonard KL, Gagne NL, Mignano JE, Duker JS, Bannon EA, Rivard MJ.
    Brachytherapy; 2011 Sep; 10(4):331-9. PubMed ID: 21349775
    [Abstract] [Full Text] [Related]

  • 27. Posterior uveal melanoma treated with I-125 brachytherapy or primary enucleation.
    Krohn J, Monge OR, Skorpen TN, Mørk SJ, Dahl O.
    Eye (Lond); 2008 Nov; 22(11):1398-403. PubMed ID: 17585309
    [Abstract] [Full Text] [Related]

  • 28. Ruthenium-106 eye plaque brachytherapy in the conservative treatment of uveal melanoma: evaluation of 175 patients treated with 150 Gy from 1981-1989.
    Pötter R, Janssen K, Prott FJ, Widder J, Haverkamp U, Busse H, Müller RP.
    Front Radiat Ther Oncol; 1997 Nov; 30():143-9. PubMed ID: 9205894
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. 106Ruthenium eye plaque brachytherapy in the management of medium sized uveal melanoma.
    Jiang P, Purtskhvanidze K, Kandzia G, Neumann D, Luetzen U, Siebert FA, Roider J, Dunst J.
    Radiat Oncol; 2020 Jul 29; 15(1):183. PubMed ID: 32727533
    [Abstract] [Full Text] [Related]

  • 31. Long-term visual acuity outcomes in patients with uveal melanoma treated with 125I episcleral OSU-Nag plaque brachytherapy.
    Wisely CE, Hadziahmetovic M, Reem RE, Hade EM, Nag S, Davidorf FH, Martin D, Cebulla CM.
    Brachytherapy; 2016 Jul 29; 15(1):12-22. PubMed ID: 26525215
    [Abstract] [Full Text] [Related]

  • 32. Cell proliferation activity in posterior uveal melanoma after Ru-106 brachytherapy: an EORTC ocular oncology group study.
    Pe'er J, Stefani FH, Seregard S, Kivela T, Lommatzsch P, Prause JU, Sobottka B, Damato B, Chowers I.
    Br J Ophthalmol; 2001 Oct 29; 85(10):1208-12. PubMed ID: 11567966
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Strabismus in adults with uveal melanoma following episcleral plaque brachytherapy.
    Dawson E, Sagoo MS, Mehta JS, Comer R, Hungerford J, Lee J.
    J AAPOS; 2007 Dec 29; 11(6):584-8. PubMed ID: 17588793
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Outcomes of choroidal melanomas treated with eye physics plaques: A 25-year review.
    Le BHA, Kim JW, Deng H, Rayess N, Jennelle RL, Zhou SY, Astrahan MA, Berry JL.
    Brachytherapy; 2018 Dec 29; 17(6):981-989. PubMed ID: 30082188
    [Abstract] [Full Text] [Related]

  • 39. Vision Loss Following Episcleral Brachytherapy for Uveal Melanoma: Development of a Vision Prognostication Tool.
    Aziz HA, Singh N, Bena J, Wilkinson A, Singh AD.
    JAMA Ophthalmol; 2016 Jun 01; 134(6):615-20. PubMed ID: 27101414
    [Abstract] [Full Text] [Related]

  • 40. Regression of uveal melanoma after ru-106 brachytherapy and thermotherapy based on metabolic activity measured by positron emission tomography/computed tomography.
    Lee CS, Lee SC, Lee K, Kwon HJ, Yi JH, Cho A.
    Retina; 2014 Jan 01; 34(1):182-7. PubMed ID: 23719400
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.